Biotech's movers for the week of August 3rd and a preview of the week ahead
- 15 minutes ago
- 1 min read
Biotech markets rallied on the FDA approvals of Moderna's mRNA flu vaccine and Replimune's viral immunotherapy for melanoma in hopes that it confirms a constructive direction by new leadership there.










.png)